[email protected]

国际临床研究杂志

International Journal of Clinical Research

您当前位置:首页 > 精选文章

International Journal of Clinical Research. 2026; 10: (6) ; 10.12208/j.ijcr.20260299 .

Efficacy analysis of three-dimensional conformal radiotherapy combined with chemotherapy in the treatment of local recurrence of lung cancer
三维适形放疗联合化疗治疗肺癌局部复发的疗效分析

作者: 陈子豪 *

广西医科大学 广西南宁

*通讯作者: 陈子豪,单位:广西医科大学 广西南宁; ;

引用本文: 陈子豪 三维适形放疗联合化疗治疗肺癌局部复发的疗效分析[J]. 国际临床研究杂志, 2026; 10: (6) : 112-114.
Published: 2026/6/11 10:30:06

摘要

目的 观察不同方案医治肺癌局部复发的效果。方法 选取2024年4月-2025年8月我科室收治的70例患者病历资料展开分析,对照组35例患者接受常规放射治疗,对观察组35例患者行三维适形放疗(3-DCRT)+化疗治疗方案,对比两组患者的治疗结局。结果 在总有效率上,观察组vs.对照组为85.71% vs.51.43%,差异有统计学意义(P<0.05)。治疗过程中,组间患者毒性反应发生率相近,即差异不显著(P>0.05)。结论 对肺癌局部复发患者行3-DCRT联合化疗治疗,和单纯放疗相比较,能更好的控制病情,且基本不会增加不良反应发生率,远期疗效较好,值得推广。

关键词: 肺癌局部复发;三维适形放疗;化疗;近期疗效;不良反应;生存率

Abstract

Objective To observe the efficacy of different treatment regimens for local recurrence of lung cancer.
Methods The medical records of 70 patients admitted to our department from April 2024 to August 2025 were selected for analysis. The control group included 35 patients who received conventional radiotherapy, while the observation group consisted of 35 patients who underwent three-dimensional conformal radiotherapy (3-DCRT) + chemotherapy treatment. The treatment outcomes of the two groups were compared.
Results In terms of overall effectiveness, the observation group vs. the control group was 85.71% vs. 51.43%, and the difference was statistically significant (P<0.05). During the treatment process, the incidence of toxic reactions in patients between the groups was similar, that is, the difference was not significant (P>0.05).
Conclusion   For patients with local recurrence of lung cancer, the treatment with 3-DCRT combined with chemotherapy is better at controlling the condition compared to simple radiotherapy, and it does not significantly increase the incidence of adverse reactions, with better long-term efficacy. It is worthy of promotion.

Key words: Local recurrence of lung cancer; Three-dimensional conformal radiotherapy; Chemotherapy; Short-term efficacy; Adverse reactions; Survival rate

参考文献 References

[1] 雒小佳,胡海峰.靶向放疗联合化疗改善局部复发性子宫内膜癌治疗的前瞻性研究[J].现代医学,2025,53(01):43-49.

[2] 王晓敏,郑晓娜,邢国臣,等.调强放疗联合TP方案化疗治疗局部晚期非小细胞肺癌的效果观察[J].实用中西医结合临床,2023,23(21):26-29.

[3] 贾臻,张火俊,曹洋森,等.立体定向放疗联合化疗治疗中央型局部晚期非小细胞肺癌的疗效分析[J].现代肿瘤医学,2022,30(16):2942-2947.

[4] 黄利生,伍方财,林柏翰,等.同步推量加速调强放疗联合化疗治疗局部晚期非小细胞肺癌的前瞻性研究[J].中国医学物理学杂志,2022,39(03):272-276.

[5] 韩松男,黄今女.期肺癌适形放疗与常规放疗结合治疗疗效分析中华当代医学,2005,3(11):29-30.

[6] 梁乾东.放疗联合尼妥珠单抗对比放化疗治疗局部复发鼻咽癌的疗效及毒性分析[D].福建医科大学,2021.

[7] 阙述浩,封巍,徐裕金.免疫治疗联合化疗,放疗及靶向药物治疗小细胞肺癌脑转移的研究进展[J].肿瘤学杂志, 2024, 30(3):177-185.

[8] 金永龙,董妮娜,清水翔星,等.PD-1抑制剂联合局部放疗用于化疗耐药晚期非特指型非小细胞肺癌1例[J].中国临床案例成果数据库, 2025, 07(01):E2445-E2445.